View in EDS

Therapeutic value of oncology drugs approved by Health Canada through Project Orbis: a cross-sectional study.

Saved in:
Bibliographic Details
Title: Therapeutic value of oncology drugs approved by Health Canada through Project Orbis: a cross-sectional study.
Authors: Lexchin J; School of Health Policy and Management, York University, Toronto, ON, Canada; Department of Family and Community Medicine, University of Toronto, Toronto, ON, Canada. Electronic address: jlexchin@yorku.ca.
Source: Journal of cancer policy [J Cancer Policy] 2025 Dec; Vol. 46, pp. 100635. Date of Electronic Publication: 2025 Aug 23.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101639933 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-5383 (Electronic) Linking ISSN: 22135383 NLM ISO Abbreviation: J Cancer Policy Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40854481
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Therapeutic value of oncology drugs approved by Health Canada through Project Orbis: a cross-sectional study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Lexchin+J%22">Lexchin J</searchLink>; School of Health Policy and Management, York University, Toronto, ON, Canada; Department of Family and Community Medicine, University of Toronto, Toronto, ON, Canada. Electronic address: jlexchin@yorku.ca.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101639933%22">Journal of cancer policy</searchLink> [J Cancer Policy] 2025 Dec; Vol. 46, pp. 100635. <i>Date of Electronic Publication: </i>2025 Aug 23.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Ltd%22">Elsevier Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101639933 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2213-5383 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2222135383%22">22135383 </searchLink><i>NLM ISO Abbreviation: </i>J Cancer Policy <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40854481
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.jcpo.2025.100635
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 100635
    Titles:
      – TitleFull: Therapeutic value of oncology drugs approved by Health Canada through Project Orbis: a cross-sectional study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lexchin J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2025 Dec
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2213-5383
          Numbering:
            – Type: volume
              Value: 46
          Titles:
            – TitleFull: Journal of cancer policy
              Type: main
ResultId 1